The present invention provides 3-(4-ethynylphenyl) pyridopyrimidinone compounds of formula A active as potential anticancer agents. The 3-(4-ethynylphenyl) pyridopyrimidinone compounds of the present application have shown promising anticancer activity in sixty human cancer cell lines.